Hormone therapy, also known as androgen deprivation therapy (ADT), is a type of treatment that reduces the level of male hormones in the body, particularly testosterone, which can promote the growth and spread of prostate cancer. Hormone therapy medications used in the treatment of prostate cancer include:

• Luteinizing hormone-releasing hormone (LHRH) agonists:
  These medications work by stopping the production of testosterone in the testicles. Some examples of LHRH agonists include: Leuprolide, Goserelin, Triptorelin
• Anti-androgens:
  These medications block the effect of testosterone on prostate cancer cells. Some examples of anti-androgens include: Bicalutamide, Flutamide, Enzalutamide
• Androgen synthesis inhibitors:
  These medications work by preventing the body from producing testosterone. Some examples of androgen synthesis inhibitors include: Abiraterone acetate
• Luteinizing hormone-releasing hormone (LHRH) antagonists:
  These medications work similarly to LHRH agonists, but they work faster to lower testosterone levels. An example of a LHRH antagonist used in the treatment of prostate cancer is: Degarelix.

Hormone therapy medications can be given alone or in combination with other treatments like chemotherapy or radiation therapy. The specific medication used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Immunotherapy is a type of cancer treatment that helps the immune system recognize and attack cancer cells. Immunotherapy medications used in the treatment of prostate cancer include:

• Sipuleucel-T:
  This is a personalized immunotherapy treatment that uses the patient’s own immune cells to attack prostate cancer cells. The patient’s white blood cells are extracted and then treated with a protein that targets prostate cancer cells. The treated cells are then infused back into the patient’s bloodstream.
• Pembrolizumab:
  This is a checkpoint inhibitor drug that helps the immune system recognize and attack cancer cells. It is used in patients whose cancer has spread or has come back after previous treatment.
• Nivolumab:
  This is another checkpoint inhibitor drug that works by blocking the PD-1 protein, which can help the immune system recognize and attack cancer cells. It is also used in patients whose cancer has spread or has come back after previous treatment.
• Ipilimumab:
  This is a type of immunotherapy drug called a CTLA-4 inhibitor that works by blocking a protein called CTLA-4, which can help the immune system recognize and attack cancer cells.

Immunotherapy medications can be given alone or in combination with other treatments like chemotherapy or radiation therapy. The specific medication used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Targeted therapy: Targeted therapy medications can attack specific proteins or genes that help cancer cells grow and spread. Some targeted therapy medications used in the treatment of prostate cancer include: Enzalutamide, Abiraterone